等待開盤 07-19 09:30:00 美东时间
+0.920
+5.94%
https://www.marijuanamoment.net/doctor-seeking-to-res
06-06 22:50
Psychedelics litigator Matthew Zorn joins HHS under RFK Jr. to lead policy. What it means for CMPS, MNMD, CYBN, PSIL & more.
05-25 04:11
Last week had Wall Street facing volatility, tech earnings disappointments, mixed labor data, and rising inflation fears. Gold hit record highs.
02-11 00:05
Clearmind Medicine's stock rose 63.9% after receiving IRB approval for its Phase I/IIa trial of CMND-100, a drug for alcohol use disorder.
2024-12-25 00:32
Psilera's trip-free psilocybin drug PSIL-006 clears key safety milestone, potentially offering a breakthrough treatment for frontotemporal dementia.
2024-09-10 02:09
AdvisorShares, a leading sponsor of actively managed exchange-traded funds (ETFs), has announced a reverse split of the issued and outstanding shares of the AdvisorShares Psychedelics ETF. The split will not change the
2024-08-31 04:16
FDA panel rejects MDMA therapy for PTSD, citing lack of evidence for benefits outweighing risks. Psychedelic stocks take a hit, with CYBN, MNMD, and ATAI down. FDA not bound by decision.
2024-06-06 03:26
Veterans Day: Can Psychedelic Treatment Help Stem PTSD-Related Suicides Among Veterans?
2023-11-13 09:39
Cannabis reform has moved one step closer to reality at the federal level on Wednesday, with the Senate Banking Committee approving the Secure and Fair Enforcement Regulation (SAFER) Banking Act.
2023-09-28 04:08
Oregon Pioneers Legal Psilocybin Therapy, But This Type Of License Has Yet To Be Issued
2023-05-02 07:06